What's New in Musculoskeletal Oncology

Lewis, Valerae O.
June 2009
Journal of Bone & Joint Surgery, American Volume;Jun2009, Vol. 91-A Issue 6, p1546
Academic Journal
The article offers developments related to musculoskeletal oncology research. A study revealed that the treatment for the bone tumor osteosarcoma remains a dilemma despite several medical interventions. Another study found that chemotherapy is not effective anymore in treating musculoskeletal diseases without surgical remissions. Another study also assessed the impact of postoperative deep infection on patient's survival with osteosarcoma.


Related Articles

  • Experience with a frontal core biopsy device in soft tissue and bone lesions. Gielen, Jan; Schepper, Arthur; Blom, Reinoud; Dyck, Pieter; Bosmans, Jan; Creytens, David; Veryser, Jan; Somville, Johan; Parizel, Paul // Skeletal Radiology;Apr2012, Vol. 41 Issue 4, p447 

    Objective: To assess the efficacy and cost of a new frontloading biopsy system, Spirotome® (system 1), in musculoskeletal lesions, and to compare the results with those obtained with commonly used biopsy devices. Methods: System 1 was used in all soft tissue lesions (STL) and osteolytic bone...

  • Survival in high-grade osteosarcoma: improvement over 21 years at a single institution. Picci, P.; Mercuri, M.; Ferrari, S.; Alberghini, M.; Briccoli, A.; Ferrari, C.; Pignotti, E.; Bacci, G. // Annals of Oncology;Jun2010, Vol. 21 Issue 6, p1366 

    Background: The purpose of this study was to analyze improvements in overall survival over 21 years (1982–2002), with a 5-year minimum follow-up, in the largest series from a single center ever reported.

  • Musculoskeletal Disorders. Estill, Cheryl Fairfield; Slavin, Thomas J.; Waters, Thomas R. // Professional Safety;Sep2002, Vol. 47 Issue 9, p45 

    Compares two national research agendas on musculoskeletal disorders in the United States. Overview of the National Occupational Research Agenda; Analysis of the National Research Council research agenda; Need to improve understanding in the areas of surveillance, etiology and interventions. ...

  • Value of measuring subpopulations of T and B lymphocytes in patients with musculoskeletal tumours. Zubović, Adnan; Cavanagh, Margaret; Hurson, Brian // Archives of Orthopaedic & Trauma Surgery;Sep2008, Vol. 128 Issue 9, p921 

    Aims of our study were to assess the clinical value of measuring subpopulations of T and B lymphocytes in patients with musculoskeletal tumours as an immunodiagnostic procedure in the primary diagnosis of tumours. In this prospective study, blood samples were obtained from 145 patients aged...

  • Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: Initial results. Hayashida, Yoshiko; Yakushiji, Toshitake; Awai, Kazuo; Katahira, Kazuhiro; Nakayama, Yoshiharu; Shimomura, Osamu; Kitajima, Mika; Hirai, Toshinori; Yamashita, Yasuyuki; Mizuta, Hiroshi // European Radiology;Dec2006, Vol. 16 Issue 12, p2637 

    The purpose of our study was to investigate whether quantitative diffusion-weighted images (DWI) were useful for monitoring the therapeutic response of primary bone tumors. We encountered 18 osteogenic and Ewing sarcomas. Magnetic resonance (MR) images were performed in all patients before and...

  • Mifamurtide: A Review of its Use in the Treatment of Osteosarcoma. Frampton, James E. // Pediatric Drugs;2010, Vol. 12 Issue 3, p141 

    Mifamurtide (liposomal muramyl tripeptide phosphatidyl ethanolamine; Mepact®) is an immunomodulator with antitumor effects that appear to be mediated via activation of monocytes and macrophages. In the EU,mifamurtide is indicated in children, adolescents, and young adults for the treatment of...

  • Microarray analysis identifies distinct gene expression profiles associated with histological subtype in human osteosarcoma. Kubista, Bernd; Klinglmueller, Florian; Bilban, Martin; Pfeiffer, Martin; Lass, Richard; Giurea, Alexander; Funovics, Phillipp T.; Toma, Cyril; Dominkus, Martin; Kotz, Rainer; Thalhammer, Theresia; Trieb, Klemens; Zettl, Teresa; Singer, Christian F. // International Orthopaedics;Mar2011, Vol. 35 Issue 3, p401 

    Osteosarcoma is the most common primary malignant bone tumour. Currently osteosarcoma classification is based on histological appearance. It was the aim of this study to use a more systematic approach to osteosarcoma classification based on gene expression analysis and to identify subtype...

  • Validation of radiographic response evaluation criteria of preoperative chemotherapy for bone and soft tissue sarcomas: Japanese Orthopaedic Association Committee on Musculoskeletal Tumors Cooperative Study. Takafumi Ueda; Norifumi Naka; Nobuhito Araki; Takeshi Ishii; Hiroyuki Tsuchiya; Hideki Yoshikawa; Kazuo Mochizuki; Tadao Tsuboyama; Junya Toguchida; Toshifumi Ozaki; Hiroaki Murata; Ikuo Kudawara; Kazuhiro Tanaka; Yukihide Iwamoto; Yasuo Yazawa; Kazuyoshi Kushida; Takanobu Otsuka; Keiji Sato // Journal of Orthopaedic Science;Jul2008, Vol. 13 Issue 4, p304 

    Abstract Background  The radiographic evaluation of the response to preoperative chemotherapy for bone and soft tissue sarcomas is based mostly on the change in primary tumor size before and after chemotherapy, as is done for many solid cancers. Its prognostic correlation, however, has...

  • Evidenzbasierte Empfehlungen der „European League Against Rheumatism“ zur Diagnostik und Therapie der Gicht. B. Grusch; B. Rintelen; B.F. Leeb // Zeitschrift für Rheumatologie;Nov2007, Vol. 66 Issue 7, p568 

    Zusammenfassung  Die Gicht kann nicht, wie es h�ufig geschieht, als leichte, unkomplizierte Erkrankung, verstanden werden. In Anbetracht des Fehlens aktueller evidenzbasierter Empfehlungen f�r die Diagnostik und Therapie der Gicht, entschloss sich die...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics